27 assets in Autoimmune Disease

Therapeutic assets addressing Autoimmune Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Autoimmune Disease	The Children's Hospital of Zhejiang University School of Medicine	P2	B (63)
Cefadroxil Anhydrous Autoimmune Disease	Mayo Clinic	P4	B (62)
Cephalexin Autoimmune Disease	Mayo Clinic	P4	B (62)
Doxycycline Autoimmune Disease	Mayo Clinic	P4	B (61)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Autoimmune Disease	Fred Hutchinson Cancer Center	P2	CCC (53)
Camustine Autoimmune Disease	Fred Hutchinson Cancer Center	P2	CCC (53)
Cytarabine Autoimmune Disease	Fred Hutchinson Cancer Center	P2	CCC (53)
Etoposide Autoimmune Disease	Fred Hutchinson Cancer Center	P2	CCC (53)
Melphalan Autoimmune Disease	Fred Hutchinson Cancer Center	P2	CCC (53)
Prednisone Autoimmune Disease	Fred Hutchinson Cancer Center	P2	CCC (53)
Acthar Autoimmune Disease	Toyos Clinic	P4	CCC (48)
Fludarabine Autoimmune Disease	The Children's Hospital of Zhejiang University School of Medicine	P1	CC (46)
Ucar T-Cell Autoimmune Disease	The Children's Hospital of Zhejiang University School of Medicine	P1	CC (46)
Naltrexone Autoimmune Disease	Truway Health, Inc.	P1/2	CC (45)
Primepro™/ Primemsk™ Autoimmune Disease	Thomas Advanced Medical LLC	P1/2	CC (45)
Lpx-Ti641 Autoimmune Disease	LAPIX Therapeutics Inc.	P1	CC (44)
Cabozantinib Autoimmune Disease	National Cancer Institute (NCI)	P1	CC (43)
Ipilimumab Autoimmune Disease	National Cancer Institute (NCI)	P1	CC (43)
Nivolumab Autoimmune Disease	National Cancer Institute (NCI)	P1	CC (43)
Idp-023 Autoimmune Disease	Indapta Therapeutics, INC.	P1	CC (41)
Jwcar201 Autoimmune Disease	RenJi Hospital	P1	CC (41)
Mesna Autoimmune Disease	Indapta Therapeutics, INC.	P1	CC (41)
Ocrelizumab Autoimmune Disease	Indapta Therapeutics, INC.	P1	CC (41)
ct103a cells Autoimmune Disease	Tongji Hospital	Early P1	C (38)
qt-219cx Autoimmune Disease	The Children's Hospital of Zhejiang University School of Medicine	Early P1	C (38)
RD06-05 CART Cell Autoimmune Disease	The Children's Hospital of Zhejiang University School of Medicine	Early P1	C (38)
Tacrolimus Autoimmune Disease	Clarteis	N/A	D (30)